JP2025508435A5 - - Google Patents
Info
- Publication number
- JP2025508435A5 JP2025508435A5 JP2024548743A JP2024548743A JP2025508435A5 JP 2025508435 A5 JP2025508435 A5 JP 2025508435A5 JP 2024548743 A JP2024548743 A JP 2024548743A JP 2024548743 A JP2024548743 A JP 2024548743A JP 2025508435 A5 JP2025508435 A5 JP 2025508435A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- cancer
- disorders
- solvate
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2202199.2 | 2022-02-18 | ||
| GBGB2202199.2A GB202202199D0 (en) | 2022-02-18 | 2022-02-18 | Compounds |
| PCT/GB2023/050369 WO2023156791A1 (en) | 2022-02-18 | 2023-02-17 | Heterocyclic compounds useful for treating a erk5-mediated disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025508435A JP2025508435A (ja) | 2025-03-26 |
| JP2025508435A5 true JP2025508435A5 (cg-RX-API-DMAC7.html) | 2026-01-08 |
Family
ID=80934460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024548743A Pending JP2025508435A (ja) | 2022-02-18 | 2023-02-17 | Ｅｒｋ５媒介性疾患を治療するのに有用な複素環式化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250154157A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4479400B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025508435A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119053604A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023220934A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3251985A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB202202199D0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023156791A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| CA2242425C (en) | 1996-02-13 | 2006-07-18 | Zeneca Limited | Quinazoline derivatives as vegf inhibitors |
| NZ331191A (en) | 1996-03-05 | 2000-03-27 | Zeneca Ltd | 4-anilinoquinazoline derivatives and pharmaceutical compositions thereof |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
| GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
| EE05345B1 (et) | 1999-02-10 | 2010-10-15 | Astrazeneca Ab | Kinasoliini derivaadid angiogeneesi inhibiitoritena |
| BR0111230A (pt) | 2000-05-31 | 2003-06-10 | Astrazeneca Ab | Composto, e, uso e processo para a preparação do mesmo |
| UA73993C2 (uk) | 2000-06-06 | 2005-10-17 | Астразенека Аб | Хіназолінові похідні для лікування пухлин та фармацевтична композиція |
| EE200300015A (et) | 2000-07-07 | 2004-10-15 | Angiogene Pharmaceuticals Limited | Kolhinooli derivaadid kui angiogeneesi inhibiitorid |
| KR20030014425A (ko) | 2000-07-07 | 2003-02-17 | 앤지오젠 파마슈티칼스 리미티드 | 혈관 손상제인 콜치놀 유도체 |
| WO2015117083A1 (en) * | 2014-01-31 | 2015-08-06 | Dana-Farber Cancer Institute, Inc. | Diazepane derivatives and uses thereof |
| EP3099693A4 (en) * | 2014-01-31 | 2017-08-16 | Dana-Farber Cancer Institute, Inc. | Uses of diazepane derivatives |
| WO2015129927A1 (en) * | 2014-02-26 | 2015-09-03 | Kyorin Pharmaceutical Co., Ltd. | Heterocyclic compounds |
| AU2020356484A1 (en) | 2019-09-27 | 2022-03-17 | Dana-Farber Cancer Institute, Inc. | ERK5 degraders as therapeutics in cancer and inflammatory diseases |
-
2022
- 2022-02-18 GB GBGB2202199.2A patent/GB202202199D0/en not_active Ceased
-
2023
- 2023-02-17 CN CN202380034888.8A patent/CN119053604A/zh active Pending
- 2023-02-17 AU AU2023220934A patent/AU2023220934A1/en active Pending
- 2023-02-17 WO PCT/GB2023/050369 patent/WO2023156791A1/en not_active Ceased
- 2023-02-17 EP EP23708272.2A patent/EP4479400B1/en active Active
- 2023-02-17 CA CA3251985A patent/CA3251985A1/en active Pending
- 2023-02-17 JP JP2024548743A patent/JP2025508435A/ja active Pending
- 2023-02-17 US US18/838,492 patent/US20250154157A1/en active Pending